Serum lactate dehydrogenase (LDH) levels have been integrated into current staging regimens (Balch et al., 2009) and elevation of LDH levels increases in specificity as disease progresses (stages II (83%), III (87%), and IV (92%)).
The carcinomas that develop using the three-stage regimen vary in metastatic potential.
The final conclusions of Bricker et al.[ 26] indicated that a two stage regimen of USS in pregnancy, one in early pregnancy (booking USS) and a second anomaly USS around 20 weeks, was recommended.
However, as discussed under staged regimens, data from open-label and randomized trials suggest that AZA can maintain remission after induction with CYC [ 7].
With the goal of reducing toxicity, recent studies have examined the use of staged regimens whereby the use of CYC is confined to the period of time needed to induce remission, after which time CYC is stopped and remission is maintained with a less toxic medication.
Baseline characteristics for both monitoring groups were compared using the Fisher exact test for categorical variables (gender, WHO staging, ART regimen) and Mann–Whitney U test for continuous variables (age, CD4+ count, hemoglobin, body mass index).
Stage IV used the stage III regimen but included patients recently given heparin.
There were significant differences between the groups with respect to age, disease type, disease stage, conditioning regimen, and GvHD prophylaxis at the 5% significance level.
Primary fibroblasts [28] were isolated from mouse skin tumor induced by two stage carcinogenesis regimen and characterized as tumor-associated fibroblast (TAF) [28], [31].
With regard to chemically-mediated skin carcinogenesis, Stat3-deficient mice were completely resistant to development of skin tumors induced by the two-stage carcinogenesis regimen and abrogation of Stat3 function by using a Stat3-specific decoy oligonucleotide inhibited the growth of skin tumors [10].
